Goldman Sachs Group Inc Gelesis Holdings, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

May 14, 2024
SELL
$0.08 - $1.34 $1,819 - $30,480
-22,747 Reduced 58.0%
16,472 $18,000
Q3 2022

Nov 10, 2022
SELL
$0.08 - $1.34 $1,819 - $30,480
-22,747 Reduced 58.0%
16,472 $0
Q2 2022

May 14, 2024
BUY
N/A
39,219 New
39,219 $61,000
Q2 2022

Aug 15, 2022
BUY
N/A
16,434 Added 72.13%
39,219 $61,000
Q1 2022

May 16, 2022
BUY
N/A
22,785 New
22,785 $103,000

Others Institutions Holding GLS

# of Institutions
1
Shares Held
4.7K
Call Options Held
0
Put Options Held
0
View Full List

About GELESIS HOLDINGS, INC.

GLS Quotes by TradingView
  • Ticker GLS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 72,946,704
  • Market Cap $1.46M
  • Description
  • Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipelin...
More about GLS
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email